2025
SJR Q2
JCR Q2 · 2,6
166 matched articles
SCIE
Journal detail
Journal of Cardiothoracic and Vascular Anesthesia
- Publisher
- W.B. Saunders
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1053077015328422
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,587
- Quartile Q2
- H-Index 103
- Cites/doc 1,6
- Docs (3y) 1.698
- Cites (3y) 2.851
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,6
- 5Y JIF 2,4
- JCI 0,6
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Anesthesiology and Pain Medicine Q2
- Cardiology and Cardiovascular Medicine Q2
Areas
- Medicine
WoS categories
- Anesthesiology | Cardiac & Cardiovascular System | Respiratory System | Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,587 | 2,6 | 2,4 | 0,6 | Q2 | 103 |
| 2024 | Q2 | Q2 | 0,68 | 2,1 | 2,2 | 0,66 | Q2 | 100 |
| 2023 | Q1 | Q2 | 0,744 | 2,3 | 2,2 | 0,7 | Q2 | 100 |
| 2022 | Q2 | Q3 | 0,694 | 2,8 | 2,5 | 0,69 | Q2 | 100 |
| 2021 | Q2 | Q3 | 0,582 | 2,9 | 2,5 | 0,62 | Q2 | 100 |
| 2020 | Q2 | Q3 | 0,678 | 2,6 | 2,2 | 0,58 | Q2 | 100 |
| 2019 | Q2 | Q3 | 0,626 | 2,3 | 1,9 | 0,53 | Q2 | 100 |
| 2018 | — | Q3 | — | 1,9 | 1,9 | 0,48 | Q2 | — |
| 2017 | Q2 | Q3 | 0,601 | 1,6 | 1,6 | 0,45 | Q2 | 100 |
| 2016 | Q2 | Q3 | 0,642 | 1,7 | 1,7 | — | — | 100 |
| 2015 | Q2 | Q3 | 0,726 | 1,5 | 1,6 | — | — | 100 |
| 2014 | Q2 | Q3 | 0,716 | 1,5 | 1,5 | — | — | 100 |
| 2013 | Q2 | Q3 | 0,693 | 1,5 | 1,3 | — | — | 100 |
| 2012 | Q1 | Q3 | 0,747 | 1,4 | 1,3 | — | — | 100 |
| 2011 | Q1 | Q3 | 0,837 | 1,6 | 1,4 | — | — | 100 |
| 2010 | Q2 | Q3 | 0,602 | 1,6 | 1,3 | — | — | 100 |
| 2009 | — | Q4 | — | 1,1 | 1,1 | — | — | — |
| 2008 | — | Q4 | — | 1 | 1,1 | — | — | — |
| 2007 | — | Q3 | — | 0,9 | 1,1 | — | — | — |
| 2006 | — | Q3 | — | 1,1 | — | — | — | — |
| 2005 | — | Q3 | — | 1 | — | — | — | — |
| 2004 | — | Q3 | — | 1 | — | — | — | — |
| 2003 | — | Q4 | — | 0,8 | — | — | — | — |
| 2002 | — | Q3 | — | 0,9 | — | — | — | — |
| 2001 | — | Q3 | — | 0,9 | — | — | — | — |
| 2000 | — | Q3 | — | 0,9 | — | — | — | — |
| 1999 | — | Q3 | — | 0,8 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
| 1997 | — | Q3 | — | 0,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ANESTHESIOLOGY | SCIE | Q2 | Q3 | 30/72 |
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 106/237 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 52/100 |
| 2025 | RESPIRATORY SYSTEM | SCIE | Q2 | Q3 | 53/107 |
| 2024 | ANESTHESIOLOGY | SCIE | Q2 | Q2 | 27/68 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 119/231 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 53/98 |
| 2024 | RESPIRATORY SYSTEM | SCIE | Q3 | Q2 | 57/108 |
| 2023 | ANESTHESIOLOGY | SCIE | Q2 | Q2 | 22/64 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 104/222 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 44/96 |
| 2023 | RESPIRATORY SYSTEM | SCIE | Q2 | Q2 | 50/101 |
| 2022 | ANESTHESIOLOGY | SCIE | Q3 | Q2 | 19/35 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 80/143 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 38/68 |
| 2022 | RESPIRATORY SYSTEM | SCIE | Q3 | Q2 | 44/66 |
| 2021 | ANESTHESIOLOGY | SCIE | Q3 | Q2 | 23/34 |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 86/143 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 42/67 |
| 2021 | RESPIRATORY SYSTEM | SCIE | Q3 | Q2 | 48/66 |
| 2020 | ANESTHESIOLOGY | SCIE | Q3 | Q2 | 20/33 |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 87/142 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 43/65 |
| 2020 | RESPIRATORY SYSTEM | SCIE | Q3 | Q3 | 44/64 |
| 2019 | ANESTHESIOLOGY | SCIE | Q3 | Q2 | 20/32 |
| 2019 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 75/138 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 38/65 |
| 2019 | RESPIRATORY SYSTEM | SCIE | Q3 | Q3 | 41/64 |
| 2018 | ANESTHESIOLOGY | SCIE | Q3 | Q3 | 23/31 |
| 2018 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 90/136 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 44/65 |
| 2018 | RESPIRATORY SYSTEM | SCIE | Q3 | Q3 | 47/63 |
| 2017 | ANESTHESIOLOGY | SCIE | Q4 | Q3 | 25/31 |
| 2017 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 90/128 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 50/65 |
| 2017 | RESPIRATORY SYSTEM | SCIE | Q4 | Q3 | 52/60 |
| 2016 | ANESTHESIOLOGY | SCIE | Q3 | — | 21/31 |
| 2016 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 88/126 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 47/63 |
| 2016 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 46/59 |
| 2015 | ANESTHESIOLOGY | SCIE | Q3 | — | 21/31 |
| 2015 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 84/124 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 49/63 |
| 2015 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 45/58 |
| 2014 | ANESTHESIOLOGY | SCIE | Q3 | — | 20/30 |
| 2014 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 80/123 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 49/60 |
| 2014 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 45/58 |
| 2013 | ANESTHESIOLOGY | SCIE | Q3 | — | 19/29 |
| 2013 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 79/125 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 49/65 |
| 2013 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 44/54 |
| 2012 | ANESTHESIOLOGY | SCIE | Q3 | — | 18/30 |
| 2012 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 78/124 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 48/68 |
| 2012 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 39/50 |
| 2011 | ANESTHESIOLOGY | SCIE | Q3 | — | 17/28 |
| 2011 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 68/117 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 45/68 |
| 2011 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 33/48 |
| 2010 | ANESTHESIOLOGY | SCIE | Q3 | — | 17/26 |
| 2010 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 66/114 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 42/68 |
| 2010 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 32/46 |
| 2009 | ANESTHESIOLOGY | SCIE | Q4 | — | 19/25 |
| 2009 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 71/95 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 51/61 |
| 2009 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 35/43 |
| 2008 | ANESTHESIOLOGY | SCIE | Q4 | — | 17/22 |
| 2008 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 63/79 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 50/56 |
| 2008 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 35/40 |
| 2007 | ANESTHESIOLOGY | SCIE | Q3 | — | 16/22 |
| 2007 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 63/75 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 45/54 |
| 2007 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 32/34 |
| 2006 | ANESTHESIOLOGY | SCIE | Q3 | — | 15/22 |
| 2006 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 54/74 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 39/52 |
| 2006 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 29/34 |
| 2005 | ANESTHESIOLOGY | SCIE | Q3 | — | 16/22 |
| 2005 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 52/72 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 41/51 |
| 2005 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 28/33 |
| 2004 | ANESTHESIOLOGY | SCIE | Q3 | — | 15/22 |
| 2004 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 47/71 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 41/51 |
| 2004 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 26/33 |
| 2003 | ANESTHESIOLOGY | SCIE | Q4 | — | 19/22 |
| 2003 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 55/70 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 44/52 |
| 2003 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 29/31 |
| 2002 | ANESTHESIOLOGY | SCIE | Q3 | — | 15/23 |
| 2002 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 48/66 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 38/52 |
| 2002 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 27/32 |
| 2001 | ANESTHESIOLOGY | SCIE | Q3 | — | 13/22 |
| 2001 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 43/65 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 36/50 |
| 2001 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 26/30 |
| 2000 | ANESTHESIOLOGY | SCIE | Q3 | — | 13/23 |
| 2000 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 38/63 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 31/45 |
| 2000 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 24/29 |
| 1999 | ANESTHESIOLOGY | SCIE | Q3 | — | 15/27 |
| 1999 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 38/67 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 34/44 |
| 1999 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 21/30 |
| 1998 | ANESTHESIOLOGY | SCIE | Q3 | — | 16/25 |
| 1998 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 34/62 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 27/39 |
| 1998 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 21/29 |
| 1997 | ANESTHESIOLOGY | SCIE | Q3 | — | 15/21 |
| 1997 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 32/62 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 23/38 |